← Browse by Condition
Medical Condition

salivary gland carcinomas

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT03556228 Phase 1, Phase 2
Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Enrollment
242 pts
Location
United States, Puert...
Sponsor
VM Oncology, LLC
View Trial →